Phenotypeca provides you with novel biologics production strains of the regulatory friendly baker's yeast, Saccharomyces cerevisiae optimised for your recombinant products.
The combination of our team and world leading yeast technology enables us to rapidly produce cost effective production strains optimised for the manufacture of specific proteins under defined bioprocessing conditions. We achieve this by harnessing the natural diversity of our billion different yeast strains to identify those strains with the preferred performance characteristics. We then breed and engineer those strains to your exact process requirements.
Working with our customers, our long-term aim is to improve access to life-saving medicines and promote sustainable manufacturing globally. Baker's yeast has been used safely by man for thousands of years, and is used today to produce many biologically active products approved by the regulatory authorities, such as insulin and vaccines, so our new platform technology is ideal for making safe efficacious biopharmaceuticals.
If you have any questions, or would like to find out more about our unique processes, please get in touch.